Steven D. Lucio

The complexities of biosimilars and the regulatory approval process.

Steven D. Lucio, 2018, The American journal of managed care.

Evaluation of the appropriate use of albumin in adult and pediatric patients.

M. Tanzi, Steven D. Lucio, M. Megellas, 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Biosimilars: Implications for health-system pharmacists.

James G Stevenson, James M Hoffman, J. Hoffman, 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Biosimilars: Primer for the Health-System Pharmacist

J. Stevenson, Steven D. Lucio, 2014 .

Biosimilars : Implications for healthsystem pharmacists

J. Hoffman, J. Stevenson, J. M. Hoffman, 2015 .

AMCP Partnership Forum: Driving New Advances in Dyslipidemia Management

S. Martin, J. Saseen, Greg Low, 2016, Journal of managed care & specialty pharmacy.

Clinical and Formulary Considerations for Biosimilars

Steven D. Lucio, 2014 .

Clarifying Our Understanding of Biosimilars in Oncology: Response to ASCO Statement.

Steven D. Lucio, 2018, Journal of Clinical Oncology.